Sionna Therapeutics (SION) EBIT (2024 - 2026)
Sionna Therapeutics' (SION) quarterly EBIT came in at -$29.6 million in Q1 2026, down 50.56% year-on-year from -$59.9 million in Q1 2025, and down 25.36% quarter-over-quarter from -$23.6 million in Q4 2025.
Sionna Therapeutics (SION) EBIT (2024 - 2026) Analysis & Trends
Sionna Therapeutics has disclosed EBIT across 3 years of filings, most recently posting -$29.6 million for Q1 2026.
- EBIT for Q1 2026 came in at -$29.6 million, down 50.56% year-over-year; the trailing twelve-month figure through Mar 2026 was -$98.9 million (down 28.36% YoY), and the FY2025 annual result was -$89.0 million, down 26.12% from the prior year.
- EBIT came in at -$29.6 million for Q1 2026 at Sionna Therapeutics, down from -$23.6 million in the prior quarter.
- In the past five years, EBIT ranged from a high of -$11.3 million in Q2 2024 to a low of -$29.6 million in Q1 2026.
- The 3-year median for EBIT is -$21.9 million (2025), against an average of -$21.0 million.
- Peak annual rise in EBIT reached 14.93% in 2025, while the deepest fall reached 94.0% in 2025.
- Sionna Therapeutics' EBIT stood at -$18.1 million in 2024, then sank by 30.22% to -$23.6 million in 2025, then declined by 25.36% to -$29.6 million in 2026.
- The last three EBIT figures came in at -$29.6 million (Q1 2026), -$23.6 million (Q4 2025), and -$23.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -15.76 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -65.83 Mn |
| 10 | Sionna Therapeutics | 1.61 Bn | 1.61 Bn | - | -29.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.60 Mn |
| Dec 31, 2025 | -23.61 Mn |
| Sep 30, 2025 | -23.81 Mn |
| Jun 30, 2025 | -21.91 Mn |
| Mar 31, 2025 | -19.66 Mn |
| Dec 31, 2024 | -18.13 Mn |
| Sep 30, 2024 | -27.98 Mn |
| Jun 30, 2024 | -11.29 Mn |
| Mar 31, 2024 | -13.15 Mn |